Health TrialsbyHealthPanel

Turkish Adaptation of the Pain and Smoking Inventory

ConditionChronic Pain
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorHacettepe University

About this trial

The purpose of this study is to perform the Turkish cross-cultural adaptation of the Pain and Smoking Inventory (PSI) and to comprehensively evaluate its reliability, validity, and psychometric properties among daily cigarette smokers with chronic pain.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 18 years and older.

Having a diagnosis of chronic pain that has persisted for at least 3 months.

Smoking at least 5 cigarettes per day (within the last 30 days).

Being able to read and write in Turkish.

Disqualifiers

Having a diagnosis of active psychosis or severe depression.

Having a diagnosis of cognitive impairment or intellectual disability.

Having severe alcohol dependence or substance use disorder.

Having reading and writing difficulties to a degree that prevents completing the questionnaire independently.

Trial population

The study population consists of adult patients aged 18 and older who present to the outpatient clinic with chronic musculoskeletal or systemic pain and are also daily cigarette smokers. The sample will be selected from individuals who are being followed up or treated at a state hospital. It includes individuals from various sociodemographic backgrounds who meet the specific pain duration and smoking quantity criteria, representing a clinical sample of smoking chronic pain patients in Turkey.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

200 Participants
are grouped into 1 trial group
Group A: Smokers with Chronic Pain

Trial outcomes

Primary outcomes

1

Turkish Pain and Smoking Inventory (PSI-TR)

The Pain and Smoking Inventory (PSI) is a 9-item self-report scale designed to assess the perceived interrelations between chronic pain and tobacco smoking. It measures three conceptual domains: pain as a motivator for smoking, smoking as a coping strategy for pain, and pain as a barrier to smoking cessation. Each item is scored on a 7-point Likert-type scale ranging from 0 to 6. The total score ranges from 0 to 54, where higher scores indicate a stronger perceived relationship between pain and smoking behaviors.

Time frame
at baseline

Secondary outcomes

1

Fagerström Test for Nicotine Dependence

A 6-item scale assessing the severity of nicotine dependence (scores range from 0 to 10; higher scores indicate higher dependence).

Time frame
at baseline
2

Numerical Rating Scale

An 11-point scale assessing average pain intensity over the last week (scores range from 0 to 10; 0 = no pain, 10 = worst possible pain).

Time frame
at baseline
3

Pain Disability Index

A 7-item questionnaire measuring the impact of chronic pain on daily life activities across seven domains (scores range from 0 to 70; higher scores indicate greater disability).

Time frame
at baseline
4

Pain Self-Efficacy Questionnaire

A 10-item instrument assessing confidence in performing daily activities despite pain (scores range from 0 to 60; higher scores indicate higher self-efficacy).

Time frame
at baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hacettepe University

Lead sponsor

Bingol University

Sponsor institution

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: